Related Experiment Video
Updated: Apr 25, 2026

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
Microbial metabolite Enterobactin impairs mitochondrial respiration and alleviates colitis
Vinita Kushwaha1, Beng San Yeoh1, Piu Saha1
1UT Microbiome Consortium, Department of Physiology & Pharmacology, The University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA.
Background And Aims:
Host-microbe interactions critically shape cellular metabolism and immune responses. The bacterial siderophore enterobactin (Ent) is known for pilfering iron from the host, but recent evidence suggests that it may also deliver iron to host mitochondria. Its impact on mitochondrial respiration, however, remains poorly understood. Here, we assess the interplay among Ent, iron, and lipocalin-2 (Lcn2, which sequesters Ent) on mitochondrial function. We also examine the effects of the 2, 3-dihydroxybenzoic acid (2, 3-DHBA), the monomeric derivative of Ent, and the mammalian siderophore 2, 5-DHBA in a murine model of colitis.
Methods:
Murine bone marrow-derived macrophages (BMDMs) and the human model intestinal epithelial cells (IEC) were treated with Ent, with or without iron or rec-Lcn2, and mitochondrial respiration was assessed via Seahorse XFe96 analyzer. For in vivo study, mice were treated with dextran sulfate sodium (DSS) to induce colitis and administered with 2, 3-DHBA or 2, 5-DHBA.
Results:
Iron-free Ent impaired mitochondrial oxidative phosphorylation in BMDMs and IEC, as evidenced by reduced ATP production and elevated reactive oxygen species. These effects of Ent were mitigated by iron saturation or upon co-administered with rec-Lcn2. Intriguingly, administration of 2, 3-DHBA, but not 2, 5-DHBA, to mice with DSS-induced colitis attenuated inflammation, increased expression of tight junction proteins, preserved epithelial architecture, and promoted mucosal repair. 2, 3-DHBA treatment also enhanced mitochondrial biogenesis, dynamics, and redox balance.
Conclusions:
Ent in its 2, 3-DHBA form confers mucosal protection, despite its inhibitory effects on mitochondrial respiration. These findings suggest that modulating mitochondrial activity, thus reducing cellular metabolism, may be beneficial during colitis and position 2, 3-DHBA as a promising microbiota-derived metabolite for therapeutic intervention in inflammatory bowel disease.
Insights
The bacterial siderophore enterobactin (Ent) derivative, 2,3-DHBA, protects the gut lining during colitis by reducing inflammation and promoting repair. This suggests microbiota metabolites can therapeutically modulate mitochondrial function in inflammatory bowel disease.
Area of Science:
- Microbiology
- Immunology
- Mitochondrial Biology
Background:
- Host-microbe interactions influence host metabolism and immunity.
- Bacterial siderophores like enterobactin (Ent) typically acquire iron but may also affect host mitochondria.
- The role of Ent and its derivatives in mitochondrial function and inflammatory conditions like colitis is poorly understood.
Purpose of the Study:
- To investigate the impact of Ent, iron, and lipocalin-2 (Lcn2) on mitochondrial function.
- To evaluate the therapeutic potential of Ent's monomeric derivative, 2,3-DHBA, and a mammalian siderophore, 2,5-DHBA, in a murine model of colitis.
Main Methods:
- Mitochondrial respiration was assessed in macrophages and intestinal epithelial cells treated with Ent, iron, or Lcn2.
- Colitis was induced in mice using dextran sulfate sodium (DSS) and treated with 2,3-DHBA or 2,5-DHBA.
Main Results:
- Iron-free Ent impaired mitochondrial oxidative phosphorylation, reducing ATP and increasing reactive oxygen species.
- These effects were reversed by iron or Lcn2.
- 2,3-DHBA, but not 2,5-DHBA, attenuated colitis, enhanced epithelial repair, and improved mitochondrial function and redox balance in vivo.
Conclusions:
- The Ent derivative 2,3-DHBA provides mucosal protection in colitis, despite inhibiting mitochondrial respiration.
- Modulating mitochondrial activity may be beneficial in colitis.
- 2,3-DHBA is a potential therapeutic agent for inflammatory bowel disease derived from gut microbiota.
More Related Videos
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
Related Concept Videos
Microbiota of the Large Intestine
Functions of the Gut Microbiota
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease II: Ulcerative Colitis
Microbial Interactions: Mutualism
Amino Acid Catabolism